<div class="table-wrap table anchored whole_rhythm" id="Tab2">
<h3>Table 2</h3>
<!--caption a7--><div class="caption"><p id="__p5">Overview of results for the elderly Japanese subpopulation of BOOST INTENSIFY ALL</p></div>
<div data-largeobj="" data-largeobj-link-rid="largeobj_idm139982954080640" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table">
<thead><tr>
<th rowspan="1" colspan="1" align="left">Characteristic</th>
<th rowspan="1" colspan="1" align="left">
<em>n</em>
</th>
<th rowspan="1" colspan="1" align="left">IDegAsp BID</th>
<th rowspan="1" colspan="1" align="left">
<em>n</em>
</th>
<th rowspan="1" colspan="1" align="left">BIAsp 30 BID</th>
<th rowspan="1" colspan="1" align="left">IDegAsp–BIAsp 30</th>
</tr></thead>
<tbody>
<tr><td colspan="6" rowspan="1" align="left">HbA<sub>1c</sub>, (mmol/mol)</td></tr>
<tr>
<td rowspan="1" colspan="1" align="left"> Baseline<br> End of trial</td>
<td rowspan="1" colspan="1" align="left">44<br>44</td>
<td rowspan="1" colspan="1" align="left">67.0 (6.5)<br>53.2 (7.2)</td>
<td rowspan="1" colspan="1" align="left">28<br>28</td>
<td rowspan="1" colspan="1" align="left">67.8 (8.6)<br>53.5 (7.9)</td>
<td rowspan="1" colspan="1" align="left">ETD: −0.10 [−3.38; 3.18]<sub>95% CI</sub>, <em>p  </em>= 0.9521</td>
</tr>
<tr><td colspan="6" rowspan="1" align="left">HbA<sub>1c</sub>, (%)</td></tr>
<tr>
<td rowspan="1" colspan="1" align="left"> Baseline<br> End of trial</td>
<td rowspan="1" colspan="1" align="left">44<br>44</td>
<td rowspan="1" colspan="1" align="left">8.3 (0.6)<br>7.0 (0.7)</td>
<td rowspan="1" colspan="1" align="left">28<br>28</td>
<td rowspan="1" colspan="1" align="left">8.4 (0.8)<br>7.0 (0.7)</td>
<td rowspan="1" colspan="1" align="left">ETD: −0.01 [−0.31; 0.29]<sub>95% CI</sub>, <em>p  </em>= 0.9521</td>
</tr>
<tr><td colspan="6" rowspan="1" align="left">FPG, (mg/dL)</td></tr>
<tr>
<td rowspan="1" colspan="1" align="left"> Baseline<br> End of trial</td>
<td rowspan="1" colspan="1" align="left">44<br>44</td>
<td rowspan="1" colspan="1" align="left">147.2 (40.6)<br>92.5 (26.8)</td>
<td rowspan="1" colspan="1" align="left">28<br>28</td>
<td rowspan="1" colspan="1" align="left">151.7 (46.0)<br>125.9 (40.3)</td>
<td rowspan="1" colspan="1" align="left">ETD: −33.58 [−49.63; −17.53]<sub>95% CI</sub>, <em>p </em> &lt; 0.0001</td>
</tr>
<tr><td colspan="6" rowspan="1" align="left">FPG, (mmol/L)</td></tr>
<tr>
<td rowspan="1" colspan="1" align="left"> Baseline<br> End of trial</td>
<td rowspan="1" colspan="1" align="left">44<br>44</td>
<td rowspan="1" colspan="1" align="left">8.2 (2.3)<br>5.1 (1.5)</td>
<td rowspan="1" colspan="1" align="left">28<br>28</td>
<td rowspan="1" colspan="1" align="left">8.4 (2.6)<br>7.0 (2.2)</td>
<td rowspan="1" colspan="1" align="left">ETD: −1.86 [−2.75; −0.97]<sub>95% CI</sub>, <em>p  </em>&lt; 0.0001</td>
</tr>
<tr><td colspan="6" rowspan="1" align="left">Insulin dose (U)</td></tr>
<tr>
<td rowspan="1" colspan="1" align="left"> Baseline<br> End of trial</td>
<td rowspan="1" colspan="1" align="left">43<br>43</td>
<td rowspan="1" colspan="1" align="left">27.0 (13.8)<br>34.9 (20.3)</td>
<td rowspan="1" colspan="1" align="left">28<br>28</td>
<td rowspan="1" colspan="1" align="left">22.8 (11.8)<br>39.3 (21.7)</td>
<td rowspan="1" colspan="1" align="left">ETR: 0.78 [0.65; 0.95]<sub>95% CI</sub>, <em>p  </em>= 0.0121</td>
</tr>
</tbody>
</table></div>
<div id="largeobj_idm139982954080640" class="largeobj-link align_right" style="display: none"><a target="object" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349271/table/Tab2/?report=objectonly">Open in a separate window</a></div>
<div class="tblwrap-foot"><p id="__p6"><em>BIAsp 30</em> biphasic insulin aspart 30, <em>BID</em> twice daily, <em>CI</em> confidence interval, <em>ETD</em> estimated treatment difference, <em>ETR</em> estimated treatment ratio, <em>FPG</em> fasting plasma glucose, <em>HbA</em><sub><em>1c</em></sub> glycated hemoglobin, <em>IDegAsp</em> insulin degludec/insulin aspart, <em>n</em> number of patients</p></div>
</div>